APA (7th ed.) Citation

YT, L., CF, L., HC, W., YH, J., & YH, K. (2023). Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab. Frontiers in immunology, 14, 1131448. https://doi.org/10.3389/fimmu.2023.1131448

Chicago Style (17th ed.) Citation

YT, Lin, Li CF, Wu HC, Jan YH, and Kuo YH. "Case Report: Heterogenous SMARCA4-deficient Thoracic Non-small Cell Lung Carcinoma with Various Responses to Nivolumab." Frontiers in Immunology 14 (2023): 1131448. https://doi.org/10.3389/fimmu.2023.1131448.

MLA (9th ed.) Citation

YT, Lin, et al. "Case Report: Heterogenous SMARCA4-deficient Thoracic Non-small Cell Lung Carcinoma with Various Responses to Nivolumab." Frontiers in Immunology, vol. 14, 2023, p. 1131448, https://doi.org/10.3389/fimmu.2023.1131448.